Terra Innovatum Global N.V.
Business
Terra Innovatum Global N.V. is a nuclear reactor developer designing and commercializing SOLO, a compact 1MWe micro-modular nuclear reactor intended for direct sale to industrial, logistics, data center, healthcare, and underserved-community customers. SOLO uses low-enriched uranium fuel, helium cooling, and a 2.5-meter concrete monolith for passive safety; the company plans manufacturing through contract suppliers with final assembly in the U.S., Europe, and Asia. Terra targets first commercial deployment by 2028 and intends to provide reactor sales alongside service and maintenance packages throughout reactor operational life.
Summary from 10-K filed 2026-07-01
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| General and administrative | 32 | 78,000 | |
| Development costs | 1 | 75,000 | |
| Total operating expenses | 34 | 153,000 | |
| Loss from operations | −34 | −153,000 | |
| Other income - related party | — | 129,000 | |
| Other expense, net | −2 | — | |
| Interest expense | −1 | — | |
| Change in fair value - share settled contingent liability | 560 | — | |
| Change in fair value - warrant liabilities | 17 | — | |
| Total other income, net | 573 | 129,000 | |
| Income (loss) before income taxes | 540 | −24,000 | |
| (Provision) benefit for income taxes | — | −10,000 | |
| Net income (loss) | 540 | −34,000 | |
| Change in foreign currency translation adjustment | −10 | 1,000 | |
| Total comprehensive income (loss) | 529 | −33,000 | |
| Net income per share - basic (in Dollars per share) | 9.74 | — | |
| Weighted-average ordinary shares outstanding - basic (in Shares) | 55 | 48 | |
| Net income per share - diluted (in Dollars per share) | 9.74 | — | |
| Weighted-average ordinary shares outstanding - dilutive (in Shares) | 55 | 48 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 103 | 69,000 | — | |
| Accounts receivable, net | 4,000 | — | — | |
| Prepaid expenses and other current assets | 3 | 65,000 | — | |
| Total current assets | 106 | 134,000 | — | |
| Equipment, net | 102,000 | — | — | |
| Total assets | 106 | 134,000 | — | |
| Accounts payable | 1 | 32,000 | — | |
| Accrued expenses and other current liabilities | 2 | 21,000 | — | |
| Total current liabilities | 3 | 53,000 | — | |
| Related party loan, non-current | — | 107,000 | — | |
| Share-settled contingent liability | 186 | — | — | |
| Warrant liabilities | 10 | — | — | |
| Other non-current liabilities | 8,000 | 6,000 | — | |
| Total liabilities | 200 | 166,000 | — | |
| Commitments and contingencies (Note 11) | — | — | — | |
| Ordinary shares (0.01 par value, 500,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 110,226,198 shares issued and outstanding as of December 31, 2025 and 47,500,000 issued and outstanding as of December 31, 2024) | 1 | 551,000 | — | |
| Convertible Preferred Shares (100 par value, 8,040 shares authorized as of December 31, 2025 and no shares authorized at December 31, 2024; 20 shares issued and outstanding as of December 31, 2025 and no issued and outstanding as of December 31, 2024) | 3 | — | — | |
| Additional paid-in capital | 519 | −548,000 | — | |
| Accumulated deficit | −607 | −37,000 | — | |
| Accumulated other comprehensive income | −10 | 2,000 | — | |
| Total shareholders deficit | −94 | −32,000 | — | |
| Total liabilities and shareholders deficit | 106 | 134,000 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 |
|---|---|---|---|
| Unrealized foreign exchange gain | 54,000 | — | |
| Loss on issuance of bridge loan and warrant liability | 1 | — | |
| Change in fair value of share-settled contingent liability | −560 | — | |
| Share-based compensation | 20 | — | |
| Remeasurement of bridge loan | −16,000 | — | |
| Interest expense - non-cash | 1 | — | |
| Depreciation expense | 10,000 | — | |
| Issuance costs allocated to liability classified warrants | 9,000 | — | |
| Due from related parties | — | 9,000 | |
| Prepaid expenses and other current assets | −3 | −67,000 | |
| Accounts receivable, net | −5,000 | — | |
| Accounts payable | 5 | 33,000 | |
| Accrued expenses and other current liabilities | 2 | 13,000 | |
| Other non-current liabilities | 2,000 | 4,000 | |
| Net cash used in operating activities | −10 | −42,000 | |
| Purchases of equipment | −108,000 | — | |
| Net cash used in investing activities | −108,000 | — | |
| Proceeds from Bridge Loans | 6 | — | |
| Payment of debt issuance costs for Bridge Loans | −24,000 | — | |
| Proceeds from Business Combination, net of transaction costs | 70 | — | |
| Proceeds from PIPE financing | 37 | — | |
| Payments to related party loans | −116,000 | 112,000 | |
| Net cash provided by financing activities | 112 | 112,000 | |
| Effect of exchange rate changes on cash and cash equivalents | 955,000 | −3,000 | |
| Net change in cash and cash equivalents | 102 | 70,000 | |
| Cash paid for interest | — | — | |
| Cash paid for income taxes | — | — | |
| Initial value of warrant liabilities issued in connection with Bridge Loans | 6 | — | |
| Conversion of Bridge Loans | 3 | — | |
| Reclassification of excess of fair value of share-settled contingent liability over additional paid-in capital to accumulated deficit | 1,147 | — | |
| Issuance of Share-settled Contingent Liability | 1,250 | — | |
| Conversion of share-settled Contingent Liability into ordinary shares upon milestone achievement | 515 | — | |
| Issuance of ordinary shares and Advisor Warrant in exchange for services | 14 | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Terra Innovatum Global N.V.'s CIK number?
Terra Innovatum Global N.V.'s SEC CIK number is 0002067627 (2067627). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Terra Innovatum Global N.V.'s SEC filings?
All of Terra Innovatum Global N.V.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Terra Innovatum Global N.V. last report earnings?
Terra Innovatum Global N.V. (NKLR) most recently filed an earnings 8-K with the SEC on Nov 17, 2025, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001213900-25-111263). This is Terra Innovatum Global N.V.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Terra Innovatum Global N.V.'s most recent earnings 8-K?
Terra Innovatum Global N.V.'s latest earnings 8-K (Item 2.02) was filed Nov 17, 2025 under accession 0001213900-25-111263. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Terra Innovatum Global N.V.'s latest earnings 8-K →
Look up any company's CIK number →